arrow
A

André-Guy Martin

Université Laval
H指数:23
被引数:2,291

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional non-inferiority phase 3 trial (PCS-XI, NCT05820633)

前列腺癌中盆腔淋巴结超低分割与常规分割IMRT联合HDR近距离放疗的比较:一项多中心非劣效性III期试验(PCS-XI,NCT05820633)的期中分析

2026-05-130
PRE
Impact of Persistent Hypogonadism on Overall Survival After Androgen Deprivation Therapy in Localized Prostate Cancer Patients: Long-Term Prospective Data

持续性性腺功能减退对局部前列腺癌患者行雄激素剥夺治疗后总生存期的影响:长期前瞻性数据

2025-11-230
PRE
Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial

高危前列腺癌患者雄激素剥夺治疗后的生活质量和睾酮恢复: 一项III期临床试验的长期数据

2024-11-201
PRE
Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials

局限性前列腺癌雄激素剥夺治疗后睾酮恢复: 来自两项随机试验的长期数据

2024-06-015
PRE
Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5 a Groupe de Radio-Oncologie Genito-Urinaire de Quebec Led Phase 3 Trial
2024-01-019
PRE
The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients
2021-06-016
PRE
Patient Reported Acute Toxicity in PACE-B, an International Phase III Randomised Controlled Trial Comparing Stereotactic Body Radiotherapy to Conventionally Fractionated or Moderately Hypofractionated Radiotherapy (CFMHRT) for Localised Prostate Cancer
2019-09-010
PREAI